Skip to content

Drug interactions

Levoketoconazole + Pazopanib

Severity: Major

Levoketoconazole and Pazopanib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Levoketoconazole is a strong CYP3A4 inhibitor that can substantially raise pazopanib levels. It also prolongs QT, adding cardiac risk, and both drugs can cause hepatotoxicity.

What this interaction means in plain words

Levoketoconazole and Pazopanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Levoketoconazole belongs to Endocrine; Pazopanib belongs to Oncology.

Evidence level: High

Why it happens

Strong CYP3A4 inhibition reducing pazopanib clearance, with additive QT and liver effects.

What to do

Avoid if possible. If coadministered, reduce pazopanib to 400 mg daily and monitor ECG and liver tests closely.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Levoketoconazole and Pazopanib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Levoketoconazole with Pazopanib?

MediHelp rates the interaction as major. Levoketoconazole and Pazopanib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Levoketoconazole is a strong CYP3A4 inhibitor that can substantially raise pazopanib levels. It also prolongs QT, adding cardiac risk, and both drugs can cause hepatotoxicity.

How serious is the interaction between Levoketoconazole and Pazopanib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if possible. If coadministered, reduce pazopanib to 400 mg daily and monitor ECG and liver tests closely.

What other medicines interact with Pazopanib?

MediHelp also lists interactions of Pazopanib with, for example, Adagrasib, Amiodarone, Amisulpride. The full list is on the Pazopanib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in